diquafosol has been researched along with Corneal Wavefront Aberration in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ikeda, C; Koh, S; Maeda, N; Nishida, K; Oie, Y; Soma, T; Tsujikawa, M; Watanabe, H | 1 |
| Choi, S; Kim, EK; Kim, SM; Kim, TI; Lee, H; Seo, KY | 1 |
2 other study(ies) available for diquafosol and Corneal Wavefront Aberration
| Article | Year |
|---|---|
Effect of diquafosol ophthalmic solution on the optical quality of the eyes in patients with aqueous-deficient dry eye.
Topics: Administration, Topical; Aged; Aqueous Humor; Corneal Wavefront Aberration; Female; Humans; Keratoconjunctivitis Sicca; Male; Middle Aged; Ophthalmic Solutions; Polyphosphates; Purinergic P2Y Receptor Agonists; Sjogren's Syndrome; Surveys and Questionnaires; Tears; Uracil Nucleotides | 2014 |
Effect of diquafosol three per cent ophthalmic solution on tear film and corneal aberrations after cataract surgery.
Topics: Aberrometry; Administration, Ophthalmic; Aged; Corneal Wavefront Aberration; Dry Eye Syndromes; Female; Humans; Lens Implantation, Intraocular; Male; Middle Aged; Ophthalmic Solutions; Perioperative Care; Phacoemulsification; Polyphosphates; Purinergic P2Y Receptor Agonists; Retrospective Studies; Tears; Uracil Nucleotides | 2017 |